161 related articles for article (PubMed ID: 36757117)
21. The circadian changes of intraocular pressure and ocular perfusion pressure after tafluprost compared with travoprost in normal tension glaucoma.
Shin J; Lee JW; Choi BS; Yun EY; Jung JH; Kim EA; Caprioli J
J Ocul Pharmacol Ther; 2014 Dec; 30(10):803-9. PubMed ID: 25285367
[TBL] [Abstract][Full Text] [Related]
22. Preservative-free tafluprost in the treatment of open-angle glaucoma or ocular hypertension in India: a phase III clinical trial.
Chabi A; Baranak C; Lupinacci R; Herring WJ
Int J Clin Pract; 2016 Jul; 70(7):577-86. PubMed ID: 27292765
[TBL] [Abstract][Full Text] [Related]
23. Twenty-four hour efficacy with preservative free tafluprost compared with latanoprost in patients with primary open angle glaucoma or ocular hypertension.
Konstas AG; Quaranta L; Katsanos A; Riva I; Tsai JC; Giannopoulos T; Voudouragkaki IC; Paschalinou E; Floriani I; Haidich AB
Br J Ophthalmol; 2013 Dec; 97(12):1510-5. PubMed ID: 23681371
[TBL] [Abstract][Full Text] [Related]
24. A phase II study on the duration and stability of the intraocular pressure-lowering effect and tolerability of Tafluprost compared with latanoprost.
Traverso CE; Ropo A; Papadia M; Uusitalo H
J Ocul Pharmacol Ther; 2010 Feb; 26(1):97-104. PubMed ID: 20148656
[TBL] [Abstract][Full Text] [Related]
25. Prospective observational post-marketing study of tafluprost for glaucoma and ocular hypertension: short-term efficacy and safety.
Kuwayama Y; Nomura A
Adv Ther; 2014 Apr; 31(4):461-71. PubMed ID: 24615289
[TBL] [Abstract][Full Text] [Related]
26. Lens-induced myopization and intraocular pressure in young guinea pigs.
Dong L; Li YF; Wu HT; Di Kou H; Lan YJ; Wang YX; Jonas JB; Wei WB
BMC Ophthalmol; 2020 Aug; 20(1):343. PubMed ID: 32842961
[TBL] [Abstract][Full Text] [Related]
27. Ocular findings and selected ophthalmic diagnostic tests in a group of young commercially available Guinea and Skinny pigs (Cavia porcellus).
Wu D; de Linde Henriksen M; Grant K; Lyakhova T; Sharp JL; Daniels JB
Vet Ophthalmol; 2020 Mar; 23(2):234-244. PubMed ID: 31562703
[TBL] [Abstract][Full Text] [Related]
28. Switching from a preserved to a preservative-free prostaglandin preparation in topical glaucoma medication.
Uusitalo H; Chen E; Pfeiffer N; Brignole-Baudouin F; Kaarniranta K; Leino M; Puska P; Palmgren E; Hamacher T; Hofmann G; Petzold G; Richter U; Riedel T; Winter M; Ropo A
Acta Ophthalmol; 2010 May; 88(3):329-36. PubMed ID: 20546237
[TBL] [Abstract][Full Text] [Related]
29. A 1-year randomized study of the clinical and confocal effects of tafluprost and latanoprost in newly diagnosed glaucoma patients.
Fogagnolo P; Dipinto A; Vanzulli E; Maggiolo E; De Cilla' S; Autelitano A; Rossetti L
Adv Ther; 2015 Apr; 32(4):356-69. PubMed ID: 25893514
[TBL] [Abstract][Full Text] [Related]
30. Pharmacological characteristics of AFP-168 (tafluprost), a new prostanoid FP receptor agonist, as an ocular hypotensive drug.
Takagi Y; Nakajima T; Shimazaki A; Kageyama M; Matsugi T; Matsumura Y; Gabelt BT; Kaufman PL; Hara H
Exp Eye Res; 2004 Apr; 78(4):767-76. PubMed ID: 15037111
[TBL] [Abstract][Full Text] [Related]
31. Comparison of intraocular pressure measurements using rebound (TonoVet
McDonald JE; Knollinger AM; Dustin Dees D; MacLaren NE
Vet Ophthalmol; 2017 Mar; 20(2):155-159. PubMed ID: 27111099
[TBL] [Abstract][Full Text] [Related]
32. Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: Results from the VISIONARY Study Population in Spain.
Garcia-Medina JJ; Benitez-Del-Castillo J; Rodríguez-Agirretxe I; Lopez-Lopez F; Moreno-Valladares A;
J Ocul Pharmacol Ther; 2022 Apr; 38(3):252-260. PubMed ID: 35230148
[No Abstract] [Full Text] [Related]
33. Switching to Preservative-Free Tafluprost/Timolol Fixed-Dose Combination in the Treatment of Open-Angle Glaucoma or Ocular Hypertension: Subanalysis of Data from the VISIONARY Study According to Baseline Monotherapy Treatment.
Oddone F; Kirwan J; Lopez-Lopez F; Zimina M; Fassari C; Holló G;
Adv Ther; 2022 Aug; 39(8):3501-3521. PubMed ID: 35524840
[TBL] [Abstract][Full Text] [Related]
34. Comparison of corneal safety and intraocular pressure-lowering effect of tafluprost ophthalmic solution with other prostaglandin ophthalmic solutions.
Kumagami T; Wakiyama H; Kusano M; Kajiyama A; Miura Y; Uematsu M; Yoneda A; Kurihara J; Suzuma K; Kitaoka T
J Ocul Pharmacol Ther; 2014 May; 30(4):340-5. PubMed ID: 24576066
[TBL] [Abstract][Full Text] [Related]
35. Treatment of open-angle glaucoma and ocular hypertension with preservative-free tafluprost/timolol fixed-dose combination therapy: 6 case reports and clinical outcomes.
Ansari E; Chappiti S; Pavicic-Astalos J; Pinto-Bonilla JC; Riva I; Sacchi M; Saénz-Francés F
BMC Ophthalmol; 2022 Apr; 22(1):152. PubMed ID: 35366846
[TBL] [Abstract][Full Text] [Related]
36. Effect of preservative-free tafluprost on intraocular pressure, pupil diameter, and anterior segment structures in normal canine eyes.
Kwak J; Kang S; Lee ER; Park S; Park S; Park E; Lim J; Seo K
Vet Ophthalmol; 2017 Jan; 20(1):34-39. PubMed ID: 26728904
[TBL] [Abstract][Full Text] [Related]
37. The IOP-lowering effects and mechanism of action of tafluprost in prostanoid receptor-deficient mice.
Ota T; Aihara M; Saeki T; Narumiya S; Araie M
Br J Ophthalmol; 2007 May; 91(5):673-6. PubMed ID: 17124244
[TBL] [Abstract][Full Text] [Related]
38. Tafluprost/Timolol: A Review in Open-Angle Glaucoma or Ocular Hypertension.
Hoy SM
Drugs; 2015 Oct; 75(15):1807-13. PubMed ID: 26431840
[TBL] [Abstract][Full Text] [Related]
39. Tafluprost Ophthalmic Solution 0.0015 %: A Review in Glaucoma and Ocular Hypertension.
Keating GM
Clin Drug Investig; 2016 Jun; 36(6):499-508. PubMed ID: 27225879
[TBL] [Abstract][Full Text] [Related]
40. Preservative-free tafluprost/timolol fixed combination: comparative 24-h efficacy administered morning or evening in open-angle glaucoma patients.
Konstas AG; Katsanos A; Athanasopoulos GP; Voudouragkaki IC; Panagiotou ES; Pagkalidou E; Haidich AB; Giannoulis DA; Spathi E; Giannopoulos T; Katz LJ
Expert Opin Pharmacother; 2018 Dec; 19(18):1981-1988. PubMed ID: 30328725
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
